Cape Biologix

𝐓𝐡𝐚𝐭 𝐦𝐨𝐦𝐞𝐧𝐭 𝐰𝐡𝐞𝐧 𝐲𝐨𝐮 𝐠𝐞𝐭 𝐚 𝐩𝐨𝐬𝐢𝐭𝐢𝐯𝐞 𝐫𝐞𝐬𝐮𝐥𝐭 🙌 🤩

Captured this morning in the Cape Biologix bustling lab: R&D scientists Dr Jennifer Stander and Asanda Matiso excitedly examining the software readout from our chromatography machine showing the peaks they wanted!



Photo courtesy of Lulamile Dyani 🙏

Do you ever wonder to yourself, 'How can I be a more ethical scientist?'

We'd love to hear your thoughts.

Stay tuned for our next blog on the subject, coming soon.

🔬 Discovering the Benefits of Azide and BSA-Free Antibodies! 🔍

Are you familiar with the advantages of azide and BSA-free antibodies? 🌿 Let’s delve into why they’re transforming the world of antibodies. 🌿

Azide and BSA are commonly used in antibody production, but their presence can pose challenges in certain applications.

Here at Cape Biologix Technologies, all of our products are azide and BSA-free. Let's talk about some of these advantages:

1. Enhanced Compatibility: Azide and BSA-free antibodies are compatible with a wider range of applications, including immunohistochemistry (IHC), Flow Cytometry and protein assays. Researchers can achieve more specific results without the risk of interference from these additives. 🧬🔬

2. Reduced Background Noise: Eliminating azide and BSA minimises background noise, leading to more accurate staining and detection. This heightened sensitivity allows researchers to identify changes in their samples with confidence. 🎯🔍

3. Improved Safety: Safety concerns associated with Azide and potential contaminations from animal derived BSA are alleviated.

Here's to a future of breakthrough discoveries, powered by azide and BSA-free antibodies! 🌟

𝐑𝐞𝐠𝐢𝐬𝐭𝐞𝐫 𝐧𝐨𝐰 𝐟𝐨𝐫 𝐄𝐜𝐨𝐧𝐨𝐦𝐢𝐜 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐁𝐨𝐚𝐫𝐝 𝐌𝐚𝐮𝐫𝐢𝐭𝐢𝐮𝐬' 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 & 𝐁𝐢𝐨𝐭𝐞𝐜𝐡 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 🧬

Watch our Founder, Belinda Shaw, and other industry experts discuss Biopharmaceutical Research and Manufacturing. Catch them during in the Panel 4 Discussion on the 18th of October from 14:30-15:30 (UTC+4).

This event will bring together renowned local and international delegates - who are involved both directly and indirectly in this sector and aims at addressing key topics that are today influencing the global healthcare and biotech industries. In addition, this conference will demonstrate the sectoral business, investment and collaborative opportunities that Mauritius has to offer.

Learn more:

edbmauritius.org

𝐀𝐫𝐞 𝐲𝐨𝐮 𝐚 𝐒𝐨𝐮𝐭𝐡 𝐀𝐟𝐫𝐢𝐜𝐚𝐧 𝐋𝐢𝐟𝐞 𝐒𝐜𝐢𝐞𝐧𝐜𝐞𝐬 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡𝐞𝐫 𝐭𝐡𝐚𝐭'𝐬 𝐭𝐢𝐫𝐞𝐝 𝐨𝐟 𝐭𝐡𝐞 𝐛𝐥𝐨𝐨𝐝, 𝐬𝐰𝐞𝐚𝐭, 𝐚𝐧𝐝 𝐭𝐞𝐚𝐫𝐬 𝐢𝐭 𝐭𝐚𝐤𝐞𝐬 𝐭𝐨 𝐨𝐫𝐝𝐞𝐫 𝐫𝐞𝐜𝐨𝐦𝐛𝐢𝐧𝐚𝐧𝐭 𝐩𝐫𝐨𝐭𝐞𝐢𝐧𝐬 𝐟𝐫𝐨𝐦 𝐨𝐯𝐞𝐫𝐬𝐞𝐚𝐬 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬?

If you answered, "No, ordering is a piece of cake for me.", please tell us your secret. 😂 If you answered, "Yah, no. I'm gatvol of this.", you should read on.

At Cape Biologix Technologies, for a limited time only, you can purchase any of our 50+ South African manufactured 100 ul recombinant antibodies for just 𝐑𝟏𝟎𝟎𝟎! Say goodbye to long lead times, import permits, poor customer service, and high prices👋🏾 Our ISO 13485 certificated processes are in place so you can trust that we always provide high-quality products.

Contact us directly at [email protected] or click the 'Love' option if you want to be contacted by a Sales Rep within 24 hours.

𝐍𝐄𝐖 𝐏𝐑𝐎𝐃𝐔𝐂𝐓: 𝐏𝐭𝐗™ 𝐇𝐮𝐦𝐚𝐧 𝐀𝐧𝐭𝐢-𝐈𝐋-𝟐 (𝟏𝐅𝟗𝟎) 🧪

Our recombinant human monoclonal antibody against IL-2 is produced in Nicotiana benthamiana plants for use in ELISA and Western blot applications. The stringent quality control processes behind our PtX™ Human anti-IL-2 antibody ensures optimal performance and reproducibility. Its application potential and reliable performance make it an invaluable tool for scientists, clinicians, and researchers dedicated to advancing immunotherapy, immune regulation, and the understanding of immune-related diseases.

Attached is an ELISA Dose Response curve using this PtX™ Human Anti-IL-2 (1F90) antibody from 3 – 0.00137 ng/µl to detect 25 ng Human Interleukin-2 protein. Experiments were performed in triplicate, with error bars representing standard deviation (SD).

Click on the link to the product page in the comments below 📄

𝐍𝐄𝐖 𝐏𝐑𝐎𝐃𝐔𝐂𝐓: 𝐏𝐭𝐗™ 𝐇𝐮𝐦𝐚𝐧 𝐀𝐧𝐭𝐢-𝐑𝐚𝐛𝐛𝐢𝐭 𝐈𝐠𝐆 (𝐀𝟏𝟎𝐁) 🎯

PtX™ Human Anti-Rabbit IgG (A10B) is an immunoglobulin G (IgG) antibody that specifically targets and binds to rabbit IgG. This product is routinely used as capture antibody to coat plates when determining levels of rabbit primary antibodies present in biological samples. Its versatility allows researchers to choose the most suitable reporter molecule for their specific experimental requirements.

Attached is an ELISA dose response curve using PtX™ Human Anti-Rabbit IgG (A10B) to detect coated Rabbit Anti-SARS-CoV-2-Nucleocapsid at 0.5 ng/µl and increasing concentrations of antibody. Experiments were performed in triplicate, with error bars representing standard deviation (SD).

Click on the link to the product page in the comments below 📄

𝐂𝐚𝐩𝐞 𝐁𝐢𝐨𝐥𝐨𝐠𝐢𝐱 𝐩𝐫𝐞𝐬𝐞𝐧𝐭𝐞𝐝 𝐚𝐰𝐚𝐫𝐝 𝐟𝐨𝐫 𝐕𝐚𝐥𝐮𝐚𝐛𝐥𝐞 𝐂𝐨𝐧𝐭𝐫𝐢𝐛𝐮𝐭𝐢𝐨𝐧 𝐭𝐨 𝐁𝐢𝐨𝐭𝐞𝐜𝐡! 🏆

Thank you to Tim Bernard and the Pivotal Scientific team for their recognition of the potential of our plant transient expression technology and the impact we're working to make within the life sciences industry. The momentum within Cape Biologix is tangible and we have many more exciting announcements coming up shortly.

𝐂𝐚𝐩𝐞 𝐁𝐢𝐨𝐥𝐨𝐠𝐢𝐱 𝐩𝐫𝐞𝐬𝐞𝐧𝐭𝐢𝐧𝐠 𝐚𝐭 #𝐏𝐢𝐯𝐨𝐭𝐚𝐥𝐋𝐢𝐧𝐤𝐬𝟐𝟎𝟐𝟑 🔗

Today, MJ van Vuuren presented a Power Presentation to the Pivotal Links conference attendees in Oxford, UK. We're thrilled to have introduced the community to our plant transient expression technology and the unique quality benefits it affords customers seeking custom protein development, contract manufacture, and OEM services.

Thank you to Pivotal Scientific Limited for affording us the opportunity to present.

𝐖𝐞𝐥𝐥𝐧𝐞𝐬𝐬 𝐃𝐚𝐲 𝟐𝟎𝟐𝟑 🧬+🌱=🚀

Last week we hosted our inaugural Wellness Day. The team partook in health assessments, yoga classes, shoulder and neck massages, and we had a wonderfully healthy and fulling team brunch together.

Thank you Kayla Flandorp and the organising team for such a wonderful experience. We're feeling revitalised and inspired to continue to 🎯

𝐍𝐄𝐖 𝐏𝐑𝐎𝐃𝐔𝐂𝐓: 𝐏𝐭𝐗™ 𝐌𝐨𝐮𝐬𝐞 𝐀𝐧𝐭𝐢-𝐕𝐄𝐆𝐅 🚀

This product is a full-length Mouse IgG2a recombinant antibody specific to the VEGF-165ᵃ antigen. It was produced in Nicotiana benthamiana plants via Agrobacterium tumefaciens mediated infiltration.

Attached is a Western blot of decreasing amounts of commercial recombinant VEGF (17 kDa) detected using PtX™ Mouse Anti-VEGF at 1: 2 000 and an HRP conjugated anti-mouse secondary antibody.

Click on the link to the product page in the comments below 📄

𝐍𝐄𝐖 𝐏𝐑𝐎𝐃𝐔𝐂𝐓: 𝐏𝐭𝐗™ 𝐇𝐮𝐦𝐚𝐧 𝐀𝐧𝐭𝐢-𝐂𝐃𝟒𝟕 (𝐁𝟔𝐇𝟏𝟐) 🆕

Our anti-CD47 (B6H12) antibody is a high-affinity, monoclonal antibody that specifically recognizes and binds to CD47 and is suitable for use in ELISAs. This product is an ideal tool for investigating the role of CD47 in disease pathogenesis and for developing novel therapeutic strategies targeting this protein.

Click on the link to the product page in the comments below 📄

𝐑𝐞𝐜𝐨𝐠𝐧𝐢𝐭𝐢𝐨𝐧 𝐨𝐟 𝐨𝐮𝐫 𝐩𝐨𝐭𝐞𝐧𝐭𝐢𝐚𝐥🦄

Thank you to African Unicorns and its jury for highlighting us as an African start-up that has the potential to be valuated 1M$ in the next five coming years, winning the Biotech & Medtech category for their first ever addition of the awards. A special thank you to the main sponsors of the prize for supporting African innovation, Orange and BCG X.

𝐍𝐄𝐖 𝐏𝐑𝐎𝐃𝐔𝐂𝐓: 𝐏𝐭𝐗™ 𝐌𝐨𝐮𝐬𝐞 𝐀𝐧𝐭𝐢-𝐃𝐞𝐥𝐭𝐚-𝟗-𝐓𝐇𝐂 ☘️

This product is a high-affinity monoclonal antibody that is engineered to detect THC in a variety of matrices, including biological fluids and plant extracts. This product is suitable for use in immunoassays such as Western blot (1: 1 000-1: 8 000) and ELISA (1: 10 000-1: 100 000).

Click on the link in the comments below to view the product page 👇🏽

𝐌𝐚𝐤𝐞 𝐲𝐨𝐮𝐫 𝐫𝐞𝐜𝐨𝐦𝐛𝐢𝐧𝐚𝐧𝐭 𝐩𝐫𝐨𝐭𝐞𝐢𝐧𝐬 𝐢𝐧 𝐨𝐮𝐫 𝐩𝐥𝐚𝐧𝐭𝐬 💡

With our R&D and OEM service offerings you can develop your own plant-made recombinant proteins. Whether you want to explore untapped opportunities in our ISO 13485 certified transient plant expression platform, or you want to provide your discerning customers with animal-free options of your existing products, we're ready for the task.

Contact [email protected] to discuss how we can support you to achieve your product needs.

𝐒𝐞𝐞 𝐨𝐮𝐫 𝐩𝐥𝐚𝐧𝐭-𝐦𝐚𝐝𝐞 𝐩𝐫𝐨𝐭𝐞𝐢𝐧𝐬 𝐛𝐞𝐢𝐧𝐠 𝐮𝐬𝐞𝐝 𝐢𝐧 𝐭𝐡𝐞 𝐟𝐢𝐞𝐥𝐝🥳

Thank you to Lambarey, et al for using our PtX™ Human Anti-Spike RBD (CR3022) and PtX™ Spike Protein S1 (His) Ultra in their study to assess SARS-CoV-2 seroprevalence and its association with HIV-related clinical parameters in non-hospitalized patients.

Follow the link to the article in the comments below 👇🏽

SARS-CoV-2 Infection Is Associated with Uncontrolled HIV Viral Load in Non-Hospitalized HIV-Infected Patients from Gugulethu, South Africa In South Africa, high exposure to SARS-CoV-2 occurs primarily in densely populated, low-income communities, which are additionally burdened by highly prevalent Human Immunodeficiency Virus (HIV). With the aim to assess SARS-CoV-2 seroprevalence and its association with HIV-related clinical parameter...

Many thanks to 2BScientific! 🐝

Farjad Ahmed and Will Kaye, thank you for a wonderful past week of learning and sharing. We're grateful to have been able to show you the ins and outs of our operations and to have strengthened our supplier relationship. The team was very impressed by your understanding of your customers and the strategy you're pursuing going forward. We eagerly anticipate working with your team to provide your customers with our plant-made research and diagnostic reagents.

See you again at ! 🔗

𝐃𝐢𝐝 𝐲𝐨𝐮 𝐤𝐧𝐨𝐰? 🤔

Molecular farming, the use of plant systems to produce recombinant proteins, is now over 30 years old. One of the first-ever publications on plant systems is a 1980 study on the successful transformation of the marker gene for β-glucuronidase (GUS) in higher plants (Fraley, R.T et al., 1983). Today, several plant-made biological products such as monoclonal antibodies, enzymes, virus-like particles (VLPs), growth factors, therapeutics, and vaccines are produced in plants around the world.

Find a link to this historic plant-based publication in the comments below 👇🏽

Fraley, R.T.; Rogers, S.G.; Horsch, R.B.; Sanders, P.R.; Flick, J.S.; Adams, S.P.; Bittner, M.L.; Brand, L.A.; Fink, C.L.; Fry, J.S.; et al. Expression of Bacterial Genes in Plant Cells. Proc. Natl. Acad. Sci. USA 1983, 80, 4803–4807.

Expression of bacterial genes in plant cells. | Proceedings of the National Academy of Sciences Chimeric bacterial genes conferring resistance to aminoglycoside antibiotics have been inserted into the Agrobacterium tumefaciens tumor-inducing (...

𝐓𝐨𝐩 𝟏𝟔 𝐥𝐢𝐬𝐭 𝐟𝐨𝐫 𝐖𝐢𝐍 𝐅𝐔𝐍𝐃 𝐍𝐅𝐓 𝐢𝐧𝐯𝐞𝐬𝐭𝐦𝐞𝐧𝐭 𝐚𝐧𝐧𝐨𝐮𝐧𝐜𝐞𝐝👩🏽‍🔬

We are ecstatic that our umbrella company, Cape Bio Pharms, have made the top 16 list of 300+ applications for investment. WiN Fund are committed to empowering women-led health innovation start-ups & catalysing real-world impact at a grassroots level. Thank you, WiN FUND, for the belief in our mission!

WiN FUND NFT on LinkedIn: #healthinnovation #winfund After receiving over 300 applications for WiNFUND investment, we are delighted to announce the top 50 entrepreneurs shortlisted for support – congratulations!…

𝐖𝐡𝐚𝐭'𝐬 𝐢𝐧 𝐨𝐮𝐫 𝐩𝐫𝐨𝐝𝐮𝐜𝐭 𝐩𝐢𝐩𝐞𝐥𝐢𝐧𝐞? 🔮

Our priority at the moment is to rapidly expand our product catalogue so that we can provide researchers and industry professionals with a variety of recombinant proteins that are catered to general lab use and for use in the fields of oncology, neurodegenerative diseases, and infectious diseases. Here is a sneak peek into some of the products we plan to add to our product catalogue in the coming weeks.

• Human Anti-HIV-1 p24
• Mouse Anti-Tubulin
• Mouse Anti-GST
• Mouse Anti-DDDDK
• Mouse Anti-TNF-α
• Human Anti-HA
• Mouse Anti-c-Myc

Please contact [email protected] if you’d like to discuss how our product catalogue could meet your research needs.

𝐇𝐨𝐰 𝐝𝐨 𝐰𝐞 𝐞𝐧𝐬𝐮𝐫𝐞 𝐛𝐚𝐭𝐜𝐡-𝐭𝐨-𝐛𝐚𝐭𝐜𝐡 𝐜𝐨𝐧𝐬𝐢𝐬𝐭𝐞𝐧𝐜𝐲?🍏

Inconsistencies between batches can impact the quality and quantity of proteins, leading to additional costs and time for quality control and testing being passed on to life sciences researchers and industry professionals.

Thankfully, proteins produced in our transient plant-based expression are recombinant, and engineered at the genetic level, allowing for increased reproducibility of results.

Reproducibility is also woven into our ISO 13485 certified processes. We ensure that each new batch is tested against a reference batch and batch-to-batch comparison is performed for all products.

Feel free to ask us more about the batch-to-batch consistency of our plant-made expression system in the comments below.

𝐍𝐄𝐖 𝐏𝐑𝐎𝐃𝐔𝐂𝐓: 𝐏𝐭𝐗™ 𝐇𝐮𝐦𝐚𝐧 𝐀𝐧𝐭𝐢-𝐓𝐍𝐅-α 🥼

We are proud to introduce our latest product, PtX™ Human Anti-TNF-α. This product specifically targets TNF-α, a pro-inflammatory cytokine that is produced and released by various cell types. With its high specificity and binding affinity this product is an ideal tool for researchers studying TNF alpha-mediated signaling pathways and its potential as a therapeutic target. This product is also available with a Rabbit backbone.

Contact us today to learn more about our plant-made PtX™ Human Anti-TNF-α product and how it can benefit your research: https://lnkd.in/dm7rCM6q

PtX™ Human Anti-TNF-α | Cape Biologix Technologies Recombinant human monoclonal antibody against Tumor Necrosis Factor Alpha cytokine. This product is produced in Nicotiana benthamiana plants and is suitable for Western Blot and ELISA applications. 100 µg | Catalogue Number: CBT_A0013 Download: SDS / Datasheet

𝐍𝐄𝐖 𝐏𝐑𝐎𝐃𝐔𝐂𝐓: 𝐏𝐭𝐗™ 𝐑𝐚𝐛𝐛𝐢𝐭 𝐀𝐧𝐭𝐢-𝐁𝐒𝐀 🙌

Serum albumin is a major protein component of plasma with a molecular weight of 66kDa. It is synthesized in the liver as a non-glycosylated, negatively charged protein, capable of binding numerous lipophilic compounds, transporting fatty acids and regulating blood osmotic pressure. Our new PtX™ Rabbit Anti-BSA binds bovine serum albumin and is suitable for use in Western blot and ELISA applications.

Visit the product page here: https://lnkd.in/d77rgcqz

PtX™ Rabbit Anti-BSA | Cape Biologix Technologies Recombinant rabbit monoclonal antibody against Bovine Serum Albumin protein. This product is produced in Nicotiana benthamiana plants and is suitable for Western Blot and ELISA applications. 100 µg | Catalogue Number: CBT_A0014 Download: SDS / Datasheet

𝐍𝐄𝐖 𝐏𝐑𝐎𝐃𝐔𝐂𝐓: 𝐏𝐭𝐗™ 𝐑𝐚𝐛𝐛𝐢𝐭 𝐀𝐧𝐭𝐢-𝐁𝐒𝐀 🙌

Serum albumin is a major protein component of plasma with a molecular weight of 66kDa. It is synthesized in the liver as a non-glycosylated, negatively charged protein, capable of binding numerous lipophilic compounds, transporting fatty acids and regulating blood osmotic pressure. Our new PtX™ Rabbit Anti-BSA binds bovine serum albumin and is suitable for use in Western blot and ELISA applications.

Visit the product page here: https://capebiologix.com/product/ptx-rabbit-anti-bsa/

PtX™ Rabbit Anti-BSA | Cape Biologix Technologies Recombinant rabbit monoclonal antibody against Bovine Serum Albumin protein. This product is produced in Nicotiana benthamiana plants and is suitable for Western Blot and ELISA applications. 100 µg | Catalogue Number: CBT_A0014 Download: SDS / Datasheet

𝐏𝐥𝐚𝐧𝐭-𝐦𝐚𝐝𝐞 𝐚𝐧𝐝 𝐏𝐮𝐫𝐞 👌

To further prove the quality of our recombinant proteins we sent several of our products for Mass Spectrometry testing and we're very proud of the results. In the attached table, you can see the consistently high levels of purity of our products with most showing levels > 95%.

Follow the link to our Products in the comments below to investigate our range or pure, plant-made products 🔎

𝐂𝐚𝐩𝐞 𝐁𝐢𝐨 𝐏𝐡𝐚𝐫𝐦𝐬 𝐂𝐄𝐎 𝐚𝐝𝐝𝐫𝐞𝐬𝐬 𝐟𝐨𝐫 𝟐𝟎𝟐𝟑 📅

Cape Bio Pharms and Cape Biologix are set for 2023 to be a fantastic year for the group. Watch our CEO, Kobus Lindeque, share his review of the life sciences industry in 2022 and how he believes we will become a world-renowned diagnostics company by 2033.

Cape Bio Pharms set to flower in 2023 🚀 2023 is set to be a fantastic year for Cape Bio Pharms and Cape Biologix Technologies. Watch our CEO, Kobus Lindeque, share his review of the life sciences i...

𝐀 𝐯𝐢𝐬𝐢𝐭 𝐟𝐫𝐨𝐦 𝐭𝐡𝐞 𝐤𝐄𝐍𝐔𝐏 𝐅𝐨𝐮𝐧𝐝𝐚𝐭𝐢𝐨𝐧🤝

Last week we had the pleasure of hosting Holm Keller (far left) and Julia Kärger (far right) to discuss our ongoing strategy of responding effectively to the ever-pressing need for increased local manufacture of biologics in Africa. The kENUP Foundation has been an instrumental partner in our journey, we highly value their impeccable insights into the worldwide healthcare sector and the support they have given us over the years.

𝐖𝐞'𝐫𝐞 𝐧𝐨𝐰 𝐈𝐒𝐎 𝟏𝟑𝟒𝟖𝟓:𝟐𝟎𝟏𝟔 (𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐃𝐞𝐯𝐢𝐜𝐞 - 𝐐𝐮𝐚𝐥𝐢𝐭𝐲 𝐌𝐚𝐧𝐚𝐠𝐞𝐦𝐞𝐧𝐭 𝐒𝐲𝐬𝐭𝐞𝐦) 𝐜𝐞𝐫𝐭𝐢𝐟𝐢𝐞𝐝! ✅

This means that an independent, globally recognised Certification Body certifies that our Quality Management System complies with the world-renowned ISO 13485:2016 standard set out for the production, distribution, and export of proteins for use in research and manufacture of in-vitro diagnostic test kits.

This certificate is testimony to just how seriously we take implementing quality in everything we do. Congratulations team CBT! 🏆



See our Quality Policy in the comments below 👀